Abcam PLC
LSE:ABC
Abcam PLC
LSE:ABC
Price:
1 226 GBX
11.15%
Market Closed
Updated:
May 15, 2024
Abcam PLC
Gross Profit
|
Abcam PLC
Gross Profit Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abcam PLC
LSE:ABC
|
Gross Profit
£254.7m
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Gross Profit
£248.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abcam PLC's Gross Profit?
Gross Profit
254.7m
GBP
254.7m
GBP
Based on the financial report for Jun 30, 2022, Abcam PLC's Gross Profit amounts to 254.7m GBP.
What is Abcam PLC's Gross Profit growth rate?
Gross Profit CAGR 10Y
14%
14%
Over the last year, the Gross Profit growth was 20%. The average annual Gross Profit growth rates for Abcam PLC have been 12% over the past three years , 11% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
